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Abstract
The Aedes aegypti densovirus (AeDNV) has potential as a delivery vector for foreign nucleic acids into mosquito cells. In this
study, we investigated the ability of plasmids containing recombinant viral transducing genome to induce RNA interference
(RNAi) effects in C6/C36 cells. We then evaluated the efficiency of a recombinant AeDNV vector to induce RNAi in Aedes
albopictus larvae. We found that the expression of V-ATPase was inhibited by up to 90% at 96 h post-transfection in
transfected C6/C36 cells. In addition, the bioinsecticidal activities of various RNAi-expressing AeDNV vectors used to infect
Ae. albopictus larvae were also tested. We found that when Ae. albopictus larvae were infected with recombinant AeDNV,
expression of V-ATPase was downregulated by nearly 70% compared to controls. Furthermore, the median survival time
bioassays demonstrated that recombinant AeDNV caused more serious pathogenic effects than the wild type virus. This is
the first report showing that recombinant virus plasmid and corresponding recombinant AeDNV can be used as an effective
in vitro and in vivo RNAi delivery system, respectively.
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Introduction
Mosquito-borne diseases are a major international public health
problem that continue to pose a public health threat [1]. Chemical
insecticides, which have traditionally been used in response to
epidemics, are a major part of sustainable, integrated mosquito
management for the prevention of mosquito-borne diseases. However,
such strategies have proven to be relatively ineffective or undesirable
as a result of to the development of resistance within mosquito
populations and the negative environmental impacts [2,3]. In light of
these problems, the search for new alternative approaches that could
be applied to combat the spread of these diseases continues.
The technique of RNA interference (RNAi) is a powerful means
of suppressing the expression of specific genes and, as such,
provides a powerful new tool for the investigation of gene function
[4]. In fact, RNAi offers a great deal of potential for successful
mitigation of various crop pest insects [5–7]. Although the dsRNA-
mediated silencing of essential genes in insects can induce
antifeedant effects and, ultimately, morbidity, the efficient uptake
of dsRNA by oral or topical applications is required [5].
Unfortunately, in the case of mosquitoes, in vivo RNAi delivery
has thus far relied on microinjection [8]. Microinjection is highly
technically demanding and time-consuming, and is therefore not
suitable for high-throughput genetic analyses or practical applica-
tions, including mosquito control.
Mosquito densoviruses (MDV; family Parvoviridae, genus Brevi-
densovirus) are non-enveloped, single-stranded DNA viruses, which
are relatively stable in the environment and have the potential to
spread and persist naturally in mosquito populations. MDVs can
cause systemic infection in mosquitoes and replicate in many
different tissues, including the midgut, malpighian tubules,
fatbody, musculature, neurons, and salivary glands [9]. Plasmid-
based, infectious clones of MDV can be constructed by inserting
the intact genome into a plasmid. Once these clones are
transfected into mosquito cells, the viral genome can be released
from the plasmid vector and infectious viral particles are
produced. Using plasmid vectors, the viral genome can easily be
manipulated and recombinant viruses can be generated in vitro by
transfecting cultured mosquito cells with helper virus [10,11].
These characteristics make MDV a valuable transducing agent in
mosquito biology.
In the present study, we developed a recombinant Aedes aegypti
Densovirus (AeDNV) siRNA expression system that utilized
artificial introns and a putative mosquito U6 snRNA promoter-
driven siRNA expression cassette. The endogenous V-ATPase gene
of the Asian dengue fever mosquito, Ae. Albopictus, was targeted for
silencing both in vitro and in vivo, and bioassays were carried out in
vivo to measure the effect of recombinant viruses on larval survival.
Materials and Methods
siRNAs
Five candidate siRNAs against the gene encoding the Ae.
albopictus V-ATPase subunit A were generated using siRNA design
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ensure that they did not have significant sequence homology with
other genes. The most effective two siRNAs, as confirmed by the
RT-PCR analysis of transfected C6/36 cells, were selected to
construct the siRNA expression vector. The two siRNAs (siRNA1
and siRNA2) corresponded to the coding regions at 1,418–1,436
and 309–327 nucleotides, respectively, of the V-ATPase subunit A
mRNA (Accession no. AY864912). The control RNA (scRNA,
CGACGACTATCGTGCAATT) consisted of a unique sequence
that did not match any sequence in the genome of interest.
Plasmid construction
The DH5a strain of Escherichia coli was used for all cloning
procedures and plasmid preparation. Functional features of the
plasmids constructed included the following (Figure 1): pUCA is
the infectious clone containing the AeDNV genome (3,981 nt) in
pUC19; non-structural 1 (NS1) and structural protein (VP) genes
were transcribed from the P7 and P61 promoters in the genome,
respectively, as described previously [12]. p7NS1-GFP expresses
an NS1-green fluorescent protein (GFP) fusion protein from the p7
promoter. The construction of p7NS1-GFP was described in detail
elsewhere [11].
p7NS1-Intron-GFP was generated by inserting artificial introns
into the AgeI sites of pNS1-GFP. An artificial intron sequence was
obtained from the sequence of pCI-neo (Promega, Madison, WI,
USA) and created by artificial synthesis, and MluI and NheI sites
were introduced between the 59-donor site and the branchpoint
site to facilitate subsequent insertion of the RNAi expression
cassette.
pAnSI-1, pAnSI-2, pAeSI-1 and pAeSI-2 were constructed using
U6snRNA polymerase III (Pol III) promoters from Anopheles
gambiae (AnGam-2 Long promoter) and Aedes aegypti (Aedes-1
promoter) to express shRNAs as described in detail previously
[13]. The shRNA expression cassette was generated by artificial
synthesis and was composed of a promoter, the sense V-ATPase
target sequence, the 7-bp hairpin loop sequence (TCAAGAG) the
antisense target sequence, and a poly(T) tract to terminate Pol III
transcription. To prepare the shRNA expression vectors pAnSI-2,
pAnSI-1 and control vector pAnCSI, the An. gambiae Pol III
promoter was used to drive siRNA-1, siRNA-2, or scRNA
expression and these were subcloned into the MluI and NheI sites
of p7NS1-Intron-GFP. pAeSI-2, pAeSI-1, and control plasmid
pAeCSI were constructed using the same approach but using the
Pol III promoter of Ae. aegypti instead. All of the constructs were
confirmed by sequencing (data not shown). The plasmids used in
this study are depicted in Figure 1 and sequences of all the shRNA
expression cassettes are shown in Text S1.
Mosquito cell maintenance and transfection
Ae. albopictus C6/36 cells (ATCC CRL-1660) were grown at
28uC in Roswell Park Memorial Institute (RPMI) 1640 medium
(Gibco BRL, USA) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Gibco BRL, USA). One day before
transfection, 2610
5 cells per well were plated in six-well plates.
The transfection of different RNAi plasmids was performed using
Lipofectamine 2,000 (Invitrogen, USA), according to the manu-
facturer’s protocol. Supercoiled plasmids used for transfection
were prepared using an OMEGA endo-free Plasmid Purification
Kit (Omega, USA). The transfected cells were examined at a
wavelength of 490 nm to detect GFP expression.
Recombinant virus production
Recombinant viruses for RNAi (rAepAnSI-1, rAepAnSI-2,
rAepAeSI-1, and rAepAeSI-2) and control (rAepAnCSI and
rAepAeCSI) treatments were generated along with the infectious
clone pUCA by cotransfecting the corresponding infectious clones,
pAnSI-1, pAnSI-2, pAeSI-1, pAeSI-2, pAnCSI, or pAeCSI, with
helper plasmid pUCA into C6/36 cells according to the
Figure 1. Schematic organization of recombinant AeDNV plasmids. The p7 and p61 viral promoters drive the expression of the NS and VP
genes, respectively. In p7NS1-GFP, GFP is fused to the NS1 gene. In p7NS1-Intron-GFP, the chemical intron sequence is inserted in the AgeI site of the
NS1-GFP fusion. RNAi plasmids pAnSI-1, pAnSI-2, pAeSI-1 and pAeSI-2, contain the artificial shRNA expression cassette, which was cloned into the
MluI and NheI sites of the intron.
doi:10.1371/journal.pone.0021329.g001
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was 2:1). After a 5 day incubation, MDV-infected cells were
harvested using cell scrapers, lysed by freezing and thawing, and
then centrifuged for 10 min at 3,750 rpm. The supernatants were
kept as recombinant virus and wild-type AeDNV mixed stocks.
Mosquito maintenance and transduction
The Ae. albopictus strain used in this work was obtained from the
Center for Disease Control and Prevention of Guangdong
Province. Mosquitoes were maintained at 27uC with 70–80%
relative humidity and a 16 h: 8 h photoperiod. Larvae were fed on
yeast powder, while adults were maintained on a 10% sugar
solution.
To minimize the effect of salt concentration on larval
susceptibility to infection [11,14], 1,000 second-instar Ae. albopictus
larvae were exposed to recombinant virus rAepAnSI-1, rAepAnSI-
2, rAepAeSI-1, or rAepAeSI-2 mixed stocks by introducing them
into the beaker that contained 100 ml deionized water and 5 ml of
the mixed virus stocks, while rAepAnCSI, or rAepAeCSI mixed
stocks were used as negative controls. The blank control group,
which received no virus, was exposed to C6/36 cell culture
medium in identical conditions to the treatment groups.
After incubation for 24 h at 28uC, the larvae were transferred
back to the pans and fed regularly. Once the fluorescent larvae
were detected postexposure, they were separated into an
individual test plastic cup to facilitate the following continuous
observation for detection of portal of entry and tissue tropisms of
recombinant virus in Ae. albopictus larvae. The same transduction
was repeated, but to test of the knockdown of V-ATPase in Ae.
albopictus larvae 3 days post-transduction, the fluorescent larvae
were detected and separated into three groups according to the
location of GFP expression: in the anal papillae infection group
(API), GFP expression was restricted to the anal papillae of the
larvae; in the systemic infection group (SI), GFP expression was
distributed throughout the body; and in the systemic RNAi test
group (SRT), GFP expression was restricted to the anal papillae,
which were removed from the body, while the rest of the body was
retained for RNAi testing. Each experiment was performed in
triplicate. Fluorescent signals of the fusion protein were observed
under an inverted fluorescence microscope, and photographs were
made using a Nikon ACT-2U digital camera. Data were processed
and superimposed using Adobe Photoshop 7.0 software (Adobe
Systems Inc., San Jose, CA).
RNA extraction, reverse transcription (RT) and
quantitative real-time PCR
Total RNA was extracted from the different groups of GFP-
expressing mosquito larvae and cells at 12 h, 24 h, 48 h, 72 h, and
96 h post transfection using the Total RNA Kit I (Omega, USA).
Any residual DNA was removed with RNase-free DNase
treatment. First-strand cDNA was synthesized using an oligo
(dT) 18 primer and the M-MLV RTase cDNA Synthesis Kit
(Takara, Japan). V-ATPase mRNA levels were compared with
those of beta-actin (Accession no. DQ657949). Gene-specific
primers were designed using Beacon Designer software 7.5
(Premier Biosoft International, Palo Alto, CA, USA). Primers
specific for the V-ATPase gene were: V-ATPase-F, 59-ACGTATC-
TATGATGGCTGATTCGACCTCTC-39; and V-ATPase-R,
59- ACCGACGATGGACACCGAACCTTC-39, generating a
product of 196 bp. Primers used for beta-actin were: b-actin-F,5 9-
CCTGGGTATGGAAGCCTGCGGTATC-39; and b-actin-R,5 9-
GGCAATGATCTTGATCTTCATGGTGGATGG-39, with a
product of 195 bp.
Reactions were performed using a RealMasterMix (SYBR
Green) (Tiangen, China) and run on MX3005P Real Time PCR
System (Stratagene, La Jolla, CA, USA) according to the
instructions of the manufacturer. Each reaction contained 10 ml
of enzyme mix, 0.15 mM of each primer and 2 ml of DNA solution
along with buffer in 20 ml of reaction volume. The PCR program
used was: denaturation at 95uC for 1 min, followed by 40 cycles of
95uC for 15 s, 53uC for 30 s, and 68uC for 30 s. Each sample was
assessed in triplicate. The real-time PCR results were analyzed
using the 2
-DDCT method as described [15].
Western blots
Cells were harvested at the indicated time points after viral
infection and total protein was extracted from the cells and
mosquito groups using a Total Protein Extraction Kit (Keygen,
China) resolved on a 12% sodium dodecyl sulfate (SDS)–
polyacrylamide gel and transferred onto a polyvinylidene fluoride
(PVDF) membrane. Rabbit anti-V-ATPase polyclonal IgG and
mouse monoclonal anti-b-actin antibodies (GeneScript, USA)
were used as the primary antibodies (1:600 dilution) and
horseradish peroxidase (HRP)-conjugated goat anti-rabbit and
goat anti-mouse IgG (Sigma, USA) were used as the secondary
antibodies, respectively.
Effect of V-ATPase knock down on the lifespan of Ae.
albopictus larvae
The copy numbers of recombinant virus and AeDNV in the
three mixed viral stocks were confirmed by SYBR green-based
real-time PCR, as previously described [16]; however, the primer
sequences used for recombinant AeDNV were changed (sense, 59-
AGCAGAATCATGGCAGACAG-39; and antisense, 59-TA-
CACCGGTAGCGTAGTTGC-39) and the copy number of
recombinant virus and AeDNV were adjusted to the same ratio
(recombinant virus copy number: AeDNV copy number = 1:5) by
adding different volumes of pure AeDNV.
Newly hatched first-instar larvae (1,200 total) were randomly
divided into six groups: four recombinant virus experimental
groups from I-IV (treated with recombinant mixed stocks
rAepAnSI-1/AeDNV, rAepAnSI-2/AeDNV, rAepAeSI-1/
AeDNV, or rAepAeSI-2/AeDNV) a wild-type AeDNV-treated
group, and a control group. Larvae in all four treatment groups
were exposed to the same concentration of mixed recombinant
virus or wild type stocks to a total volume of 10 ml, and food was
withheld for 24 h. The control group, which received no virus, was
exposed to C6/36 cell culture medium in identical conditions to
the treatment groups. After 24 h, mosquito larvae were transferred
into dechlorinated tap water and fed regularly. Larval mortality
was scored every 12 h for 15 days.
The median survival time (LT50) was calculated from the time-
mortality curve of larvae that were infected by recombinant virus
and wt virus at a concentration of 1.0610
10 copies/ml.
Statistical analysis
Survival curves were formulated using the Kaplan-Meier test.
The log-rank test was used to analyze the differences between
survival curves. LT50 values were determined by probit analysis.
The LT50 values were compared between different treatments by a
one-way analysis of variance (ANOVA) followed by the Fisher’s
least significant difference test (LSD). P-values ,0.05 were
considered to be statistically significant. The SPSS computer
software version 17.0 (SPSS Inc., Chicago, IL) was used for data
analysis.
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Generation of the Pol III-mediated intronic shRNA
expression vector
We inserted the Pol III promoter-driven shRNA expression
cassettes into a chimeric intron composed of the 59 donor site from
the first intron of the human beta-globin gene and the branch and 39
acceptor site from the intron of an immunoglobulin gene heavy
chain variable region [17]. This design takes advantage of the
natural process of pre-mRNA splicing, by which introns are
removed from pre-mRNA transcripts [18]. NS1 protein is
preserved in its entirety in the recombinant genome as the NS1-
GFP fusion protein, because of the multiple activities that this
densovirus replication initiator protein possesses. Moreover, GFP
also provides a robust marker for the recombinant vector-
transfected cells in vitro and in vivo. For the intronic shRNA
expression vector, if the artificial intron is not removed in
mosquito cells, the frame-shift mutation in the fused GFP marker
will preclude fluorescence. We detected GFP in all shRNA
expression vector transfected cells, confirming the function of the
artificial intron in mosquito cells (Figure 2).
Knockdown of V-ATPase mRNA and protein expression in
C6/36 cells
The direct visualization of green fluorescence allowed us to
detect recombinant plasmids that were expressed in mosquito cells.
The first fluorescent cells were observed as early as 4 h after
transfection, but maximum levels of expression were observed
about 48 h later. At 60 h post-transfection, the efficiency was
determined by counting GFP-positive cells and total cells from six
random fields for each condition. More than 96% transfected
cells were GFP-positive determined by Fluorescence inverted
microscopy.
To compare and validate the effect of the different RNAi
vectors and determine the time-response effect of silencing V-
ATPase, C6/36 cells were transfected with pAnSI-1, pAnSI-2,
pAeSI-1, or pAeSI-2, and the expression of V-ATPase was
detected by real-time PCR and western blotting at 12, 24, 48, 72,
and 96 h post-transfection. Real-time PCR analysis showed that
the silencing effects of pAnSI-1, pAnSI-2, pAeSI-1, and pAeSI-2
on C6/36 cells varied. Of these constructs, An. gambiae Pol III
promoter-driven RNAi vectors pAnSI-1 and pAnSI-2 exhibited
significant silencing effects at all time points. The inhibition ratio
of pAnSI-1 was 35.0366.35% (p,0.01) at 12 h post-transfection
and reached a peak at 24 h (63.85616.85%) (p,0.01). The levels
of inhibition declined between 48 h (56.4863.56%; p,0.01) and
96 h (18.2166.87%; p,0.01), respectively. For pAnSI-2, effective
inhibition was observed as early as 12 h (56.5164.75%; p,0.01)
and then increased to 74.0662.97% (p,0.01) at 48 h. This was
followed by a constant decline in mRNA expression at 72 h
(68.4968.07%; p,0.01) and 96 h (59.6264.62%; p,0.01) after
transfection. In contrast, no significant expression changes were
observed in the pAnCSI-control group (p . 0.5) (Figure 3A,
graph).
However, the Ae. aegypti Pol III promoter-driven RNAi vectors
pAeSI-1 and pAeSI-2 appeared to be more effective at silencing
genes than those driven by the An.gambiae Pol III promoter.
Analysis of cells transfected with pAeSI-1 indicated that V-ATPase
knockdown was evident at 12 h (41.02613.58%; p,0.01) and
peaked at 48 h (82.0963.42%; p,0.01) post-transfection in these
cells. Cells transfected with pAeSI-2 exhibited sustained silencing
of V-ATPase expression. Maximum down-regulation of V-ATPase
by pAeSI-2 exceeded 90% at 96 h (98.13614.1%; p,0.01) post-
transfection (Figure 3B, graph).
Western blot data also indicated that both An. gambiae and Ae.
aegypti Pol III promoter-driven RNAi vectors effectively inhibited
Figure 2. Pol III-mediated intronic siRNA expression vector. Intronic shRNA is transcribed by the U6 promoter accompanied by a pre-mRNA
transcribed by the p7 promoter. After pre-mRNA splicing, the exons are ligated to form a mature mRNA. For NS1-GFP fusion protein synthesis, the
shRNA is further processed into mature siRNA capable of triggering post-transcriptional gene silencing.
doi:10.1371/journal.pone.0021329.g002
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inhibition increased over time (Figure 4). Notably, pAeSI-2 V-
ATPase protein expression dropped to undetectable levels at 96 h
post-transfection (Figure 4B, graph).
Portal of entry and tissue tropisms of recombinant virus
in Ae. albopictus larvae
Ae. albopictus larvae were exposed to recombinant virus mixed
stocks. GFP marker expression was examined under fluorescence
microscopy. The newly emerging GFP-positive larvae were
separated continuously from 1 to 3 days post-exposure. The
GFP expression was observed in 75.1%, 71.3%, 72.8%, and
78.4% larvae in rAepAnSI-1, rAepAnSI-2, rAepAeSI-1 and
rAepAeSI-2 respectively. In the different groups, respectively,
39.3%, 41.9%, 41.3% and 45.1% larvae first showed GFP in the
anal papillae; 12.8%, 15.3%, 13.0%, and 16.2% within the bristle
cell; 9.8%, 7.9%, 8.5%, and 9.0%, at the base of an anal papilla.
Other tissue locations accounted for 6.2%, 6.0%, 7.4%, and 7.1%
of the primary infection sites. Furthermore, 28.5%, 24.1%, 26.8%,
and 29.3% of larvae showed primary infection in more than one
tissue site (Table 1). Investigation into the dissemination of
recombinant virus in separated individual mosquitoes was based
on daily monitoring of GFP expression. Nearly 83.1%, 87.7%,
92.3%, and 94.7% of larvae developed other infected tissues,
including muscle fibers, the midgut, salivary glands, nerves, the
malpighian tubule, the foregut and hindgut, and others. Only
1.7%, 0.9%, 2.1%, and 1.5% of larval infection was restricted to
the anal papillae, or they lost their infected anal papillae, which
delayed or prevented further dissemination.
Knockdown of V-ATPase in Ae. albopictus larvae
The anal papillae of mosquito larvae are classic transport
epithelia that can absorb inorganic ions from extremely dilute
external media and control the ion balance between the
Figure 3. AeDNV-delivered recombinant siRNA inhibits V-ATPase mRNA expression in mosquito cells. Analysis of V-ATPase mRNA
expression in Ae. albopictus C6/36 cells after transfection with recombinant siRNA vector. (A) An. gambiae U6 promoter-driven siRNA vector. (B). Ae.
aegypti U6 promoter-driven siRNA vector. Error bars represent the standard deviation of the 2
-ggCT values for V-ATPase mRNA expression in the C6/
36 cell line as evaluated by real-time RT-PCR.
doi:10.1371/journal.pone.0021329.g003
Figure 4. AeDNV-delivered recombinant siRNA inhibits V-ATPase expression in mosquito cells. Western blot analysis of V-ATPase
expression and b-actin (loading control) protein levels in Ae. albopictus C6/36 cells after transfection with recombinant siRNA vector. (A) An. gambiae
U6 promoter-driven siRNA vectors. (B). Ae. aegypti U6 promoter-driven siRNA vectors.
doi:10.1371/journal.pone.0021329.g004
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Anal papillae are the major portal of entry of AeDNV, with
dissemination to the whole body occurring from there [16].
However, in some cases the anal papillae present a barrier to virus
dissemination, in which case the infection remains restricted to the
anal papillae. In these instances, whether the recombinant virus
restricted to the anal papillae can also result in a whole body RNAi
response is still unknown. To explore this possibility, anal papillae
from mosquitoes with infection restricted to the anal papillae were
removed and the rest of the body was collected to test the SRT
group for whole body RNAi response. Figure 5 shows the different
groups being analyzed for this purpose. The effect of recombinant
virus on V-ATPase knockdown was investigated by real time PCR
and western blot. Triplicate experiments showed that the An.
gambiae Pol III promoter-driven RNAi vectors rAnpAnSI-1
exhibited reductions in V-ATPase gene expression of 29.776
6.1% (p,0.01), 61.4767.51% (p,0.01) and 25.963.16%
(p,0.05) in the API, SI, and RT groups, respectively, while the
same groups infected with rAnpAnSI-2 exhibited reductions of
31.2267.22% (p,0.01) 64.5662.97% (p,0.01) and 27.576
7.97% (p,0.05), respectively (Figure 6A). As expected, Ae. aegypti
Pol III promoter-driven RNAi vectors showed higher rates of V-
ATPase mRNA inhibition in vivo than that of An. gambiae Pol III
promoter-driven rAepAnSI-1, reducing larval expression by
34.14613.41% (p,0.01) 69.9665.30% (p,0.01) and 23.666
2.65% (p,0.05) in the API , SI, and RT group, respectively.
rAepAnSI-2 exhibited the strongest inhibitory effect on V-ATPase
mRNA, as it reduced expression by 38.04614.70% (p,0.01),
72.8765.74% (p,0.01) and 28.79612.81% (p,0.05) in the SI,
API, and RT groups, respectively (Figure 6B). These data were
confirmed by Western blot analysis (Figure 7, graph), which
suggested that the siRNA blocked expression of V-ATPase at the
protein level in mosquito larvae.
Knockdown on the lifespan of Ae. albopictus larvae
To study the pathogenicity of recombinant densovirus in Ae.
Albopictus, newly-hatched first-instar larvae were naturally infected
by introduction of the recombinant virus mixture into the water,
and their survival was recorded. Figure 8 shows the cumulative
proportion of Ae. Albopictus that survived for longer than 15 days
when exposed to 1610
10 copies/ml of densovirus for 48 h. The
survival of mosquitoes exposed to rAepAnSI-1, rAepAnSI-2,
rAepAeSI-1, or rAepAeSI-2 was significantly different from those
exposed to wild-type AeDNV (log rank P,0.05). The LT50 values
of recombinant AeDNV-exposed mosquitoes were 8.00 (rAe-
pAnSI-1), 7.5 (rAepAnSI-2), 7.5 (rAepAeSI-1) and 7.0 days
(rAepAeSI-2) (Table 2). These LT50 values were significantly
lower than wild-type-exposed mosquitoes (10.0 days). In particu-
lar, larvae treated with rAepAeSI-2 mixed stocks exhibited the
highest pathogenic effects. Therefore, the increased mortality
observed in the recombinant virus-infected larvae was caused by
reduced V-ATPase expression in larval cells as a result of the RNAi
treatment.
Discussion
Currently, electroporation, lipid-based transfection reagents,
and nanoparticles are commonly used to transfer RNAi molecules
into cultured mosquito cells. However, despite growing interest in
the application of siRNAs for mosquito gene function analysis or
vector control, in vivo delivery has been difficult. Direct injection of
dsRNA is the most commonly used delivery method for in vivo
siRNA delivery [21–25]. However, this technique is technically
demanding and the relatively short half-lives of the delivered
dsRNA or siRNA limit their utility [26]. In contrast, viral-based
shRNA expression systems have been developed to overcome
extracellular and intracellular barriers. In addition, viral-based
shRNA delivery has the advantages of easy manipulation, higher
transfection efficiency, longer-term expression, and more persis-
tent silencing effects in vivo [27]. There are now many successful
examples of the use of viral vector-mediated RNAi to inhibit gene
expression in animal models of disease [28–30]. In addition, this
study describes a novel MDV-based siRNA delivery system for
mosquito RNA interference applications.
Although their biological characteristics make MDVs attractive
vectors for gene transfer in mosquito cells, their relatively small
genome has been a major obstacle to application. Insert size
testing suggests that 4,100–4,400 bp is the optimal genome size for
packaging. With the essential MDV inverted terminal repeats
(ITRs) 39 and 59 untranslated regions, and NS1 elements, the
expression cassette can easily surpass the packaging limits [9]. This
poses a problem for large shRNA expression cassettes. As is well
known, permanent gene suppression can be achieved by siRNAs
as stem-loop precursors transcribed from an RNA Pol II or Pol III
promoter-based vector [31], but this size limit excludes most Pol II
promoters if the entire NS1 protein is retained for replication of
the recombinant virus genome. Another frequently used strategy is
inversion of the Pol III promoter-driven shRNA cassette in the 39
end of the genome [32]. However, in the MDV genome, this
region contains the sequences necessary for the termination of
viral mRNAs [9]. To solve this, we inserted the Pol III promoter-
driven shRNA expression cassettes into a chimeric intron. When
this intron was inserted into the protein coding regions of the
MDV, mature virus mRNA sequences were unaltered after
splicing, regardless of the shRNA expression cassette used. Our
Table 1. Location and frequency of portal of entry in first-instar Ae. albopictus larvae.
Primary infection site GFP larvae number infected with recombinant virus
rAepAnSI-1 rAepAnSI-2 rAepAeSI-1 rAepAeSI-2 Total
Anal papillae (SA*) 393(244) 419(235) 413(217) 451(243) 477(290)
Bristle cell (SA) 328(169) 353(178) 330(189) 362(190) 400(206)
Base of anal papillae (SA) 98(24) 109(27) 125(34) 130(32) 144(31)
Other** (SA) 69(11) 71(9) 48(9) 59(9) 70(20)
Multiple sites 285 241 268 293 279
*SA = site alone, the location indicated was unique site of GFP expression observed.
**All locations other than the three types of primary infection indicated in the table.
doi:10.1371/journal.pone.0021329.t001
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NS1 gene and IRS in all recombinant constructs in which NS1
fusion protein and IRS mediate the excision and replication of the
recombinant genome in host cell. The continuously increasing
copy number of the self-replication vector may contribute to
highly efficient and constant down regulation in C6/36 cell than
the common RNAi plasmid vector.
Our results demonstrate that the incorporation of an intronic
strategy offers a new paradigm to overcome MDV vector size
limitations for the efficient use of RNAi in mosquitoes. This result
suggests that Drosha processing of the shRNA is relatively efficient
even when the shRNA cassette is in an intron. The success of
vectors that incorporate a synthetic intron also indicates that the
conserved sequences for mRNA splicing (59 donor, branch, and 39
acceptor sites) suffice for the efficient processing of pre-mRNAs.
Recently, the U6snRNA promoters of Ae. aegypti and An. gambiae
were characterized for the expression of shRNA targeting firefly
luciferase to mediate knockdown of a co-transfected luciferase
reporter gene in mosquito cells [13]. Because genome information
is lacking for Ae. albopictus, and the U6snRNA promoters have not
been cloned for this species, the U6snRNA promoters of Ae. aegypti
and An. gambiae were used in this study to express shRNA in Ae.
albopictus cells, and the gene-silencing effects of these two shRNA
expressing cassettes were evaluated and compared.
The characteristic RNAi effects were compared between
experiments using the An. gambiae U6 promoter and those using
the Ae. aegypti promoter. Both of the Ae. aegypti promoter-based
constructs exhibited increased silencing compared with the An.
gambiae-based constructs, whether used in cultured cells or larvae.
In particular, the pAeSI-2 construct exhibited more rapid and
Figure 5. Grouping of mosquito larvae by GFP expression location. In the systemic infection group (SI) GFP expression was distributed
throughout the body. In the anal papillae infection group (API) GFP expression was limited to the anal papillae. In the systemic RNAi test group (SRT)
The GFP anal papillae were removed (arrow shown).
doi:10.1371/journal.pone.0021329.g005
Figure 6. AeDNV-mediated expression of recombinant siRNA inhibits V-ATPase mRNA expression in mosquito larvae. Analysis of V-
ATPase mRNA expression in Ae. albopictus larvae in various expression level groups after expression of recombinant siRNA directed against V-ATPase
driven by: A, An. gambiae U6 promoter; or B, Ae. aegypti U6 promoter. Error bars represent the confidence intervals of 2
-DDCT6s for V-ATPase mRNA
expression data collected at each time point. s = the standard deviation of the DDCT value. *P,0.05.
doi:10.1371/journal.pone.0021329.g006
Recombinant Densovirus-Mediated RNA Interference
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21329sustained silencing of ATPase expression in cells. This could be due
to the genetic linkage similarity of mosquitoes, as Ae. aegypti is
closely related to Ae. albopictus than to An. gambiae. Furthermore, a
previous study showed that the An. gambiae U6 promoter is more
effective at driving RNAi-mediated gene knockdown in AG-55 An.
gambiae cells [13]. The characteristics of the promoters used in this
study should be useful for many mosquito system applications,
including functional genomic experiments, and development of
RNAi-based strategies for vector control.
Ae. albopictus was selected as the target insect because it is an
important vector of the Chikungunya (CHIKV) and dengue
(DENV) viruses. DENV is considered the most important
arbovirus disease on the planet. CHIKV, which has contributed
to epidemics in continental Africa and Asia, has caused several
serious health and economic problems.
Vacuolar ATPases (V-ATPases) a family of ATP-dependent
proton pumps, are commonly found in eukaryotic cell plasma
membranes and the membranes of intracellular compartments
[33–35]. Acidification of intracellular compartments, such as
lysosomes, endosomes, and parasitophorous vacuoles, is mediated
by V-ATPase, and is essential for entry by many enveloped
viruses, as well as invasion into, or escape from, host cells by
intracellular parasites [36]. V-ATPases are relatively conserved
among mosquitoes, such as Ae. aegypti, Culex quinquefasciatus, Ae.
albopictus and An. gambiae [37–39]. Furthermore, previous reports
have shown that V-ATPase has essential functions, making it the
best RNAi target for causing lethality in coleopteran insect pests
[5]. Therefore, given its essential role in a variety of cellular
functions, and its key role in mediating pathogenic invasion, V-
ATPase is the preferable target gene for pest control and/or
disruption of arbovirus transmission.
Systemic RNAi is a phenomenon in which local cellular uptake
of dsRNA leads to systemic spreading of the RNAi effect [40,41].
Insect systemic RNAi has been documented in several insect
Figure 7. AeDNV-mediated expression of recombinant siRNA inhibits V-ATPase expression in mosquito larvae. Western blot analysis
of V-ATPase and b-actin (loading control) protein levels in API, SI, and SRT groups transfected with siRNA driven by the: A, An. gambiae U6 promoter
or B, Ae. aegypti U6 promoter.
doi:10.1371/journal.pone.0021329.g007
Figure 8. The cumulative proportion of surviving Ae. albopictus after first-instar larvae were exposed to doses of wt-type AeDNV and
four kinds of recombinant AeDNV mixed stocks at 10
10 copies/ml.
doi:10.1371/journal.pone.0021329.g008
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Blattodea, Lepidoptera and Hemiptera[42], but there is limited
information available on the use of systemic RNAi in mosquitoes.
In our previous studies, we found that the primary portals of
AeDNV entry in Ae.albopictus were the anal papillae. For most larvae,
viral dissemination occurred from infected anal papillae to the whole
body. However, in some cases the infection was restricted to the anal
papillae, indicating that the anal papillae may be a barrier for
recombinant virus dissemination to the whole body [16]. However,
our results show that in the SRT groups studied, even if the infected
anal papillae were removed, V-ATPase was still down regulated in the
rest of the body. In other words, shRNA with restricted expression in
the anal papillae can lead to an RNAi response in the whole body.
There are still some limitations of the system, e.g. although the
pure recombinant virus can be generated by the Sindbis virus
expression system, they would lose the ability for secondary
transmission that takes place in vivo with a defective genome.
Therefore, cotransfection with wt virus is necessary for dissemi-
nation of recombinant virus in vivo from primary infection sites to
other parts. However, the problem of the persistence of
recombinant virus could be solved effectively by the construction
of nondefective hypervirulent strains, and this appears to be
feasible with the use of appropriate genetic methods in our
ongoing studies.
In conclusion, the ability to reliably deliver RNAi to mosquitoes
by recombinant viruses will not only provide a tool for functional
analysis of mosquito genes, but will have obvious commercial
application as well. RNAi provides a unique mode of action for
vector control that could complement current strategies. However,
whether this system will become a practical method for insect
control remains to be seen. Safety issues will need to be addressed,
including possible infection of non-target organisms and the risk of
gene flow into non-target organisms [43]. Although MDVs are
highly specific for mosquito hosts, and siRNA is highly selective,
more data will be needed to support the environmental safety of
genetically modified AeDNV. Analogous research regarding the
feasibility of using RNAi in the protection of crops against insect
herbivores has shown that this strategy holds great promise for the
future because it allows for the suppression of a wide range of
potential gene targets in insects [7,44]. Because chemical insecti-
cides have a limited shelf life, and their excessive and repeated use
leads to resistance, vector resurgence and environmental problems,
effective vector management requires a diversity of tools. We feel
that the relative risksof recombinant virusesarefar lower than those
posed by many chemical insecticides, while offering clear benefits in
terms of environmentally safe insect pest control.
Supporting Information
Text S1 Sequences of artificial introns and all the
shRNA expression cassettes.
(DOC)
Acknowledgments
The authors gratefully acknowledge Professor Jonathan Carlson (Colorado
State University) for kindly providing the plasmids pUCA and p7NS1-
GFP, and Dr. James K Biedler (Department of Biochemistry, Virginia
Tech) for critically reading this manuscript.
Author Contributions
Conceived and designed the experiments: JG XC. Performed the
experiments: JG HP ML YD. Analyzed the data: JG ML XC. Contributed
reagents/materials/analysis tools: JG XC. Wrote the paper: JG XC.
References
1. Tolle MA (2009) Mosquito-borne diseases. Curr Probl Pediatr Adolesc Health
Care 39: 97–140.
2. Roberts DR, Andre RG (1994) Insecticide resistance issues in vector-borne
disease control. Am J Trop Med Hyg 50: 21–34.
3. Attaran A, Roberts DR, Curtis CF, Kilama WL (2000) Balancing risks on the
backs of the poor. Nat Med 6: 729–731.
4. Hannon GJ (2002) RNA interference. Nature 418: 244–251.
5. Baum JA, Bogaert T, Clinton W, Heck GR, Feldmann P, et al. (2007) Control of
coleopteran insect pests through RNA interference. Nat Biotechnol 25:
1322–1326.
6. Mao YB, Cai WJ, Wang JW, Hong GJ, Tao XY, et al. (2007) Silencing a cotton
bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval
tolerance of gossypol. Nat Biotechnol 25: 1307–1313.
7. Tian H, Peng H, Yao Q, Chen H, Xie Q, et al. (2009) Developmental control of
a lepidopteran pest Spodoptera exigua by ingestion of bacteria expressing
dsRNA of a non-midgut gene. PLoS One 4: e6225.
8. Isoe J, Kunz S, Manhart C, Wells MA, Miesfeld RL (2007) Regulated expression of
microinjected DNA in adult Aedes aegypti mosquitoes. Insect Mol Biol 16: 83–92.
9. Carlson J, Suchman E, Buchatsky L (2006) Densoviruses for control and genetic
manipulation of mosquitoes. Adv Virus Res 68: 361–392.
10. Barreau C, Jousset FX, Bergoin M (1996) Pathogenicity of the Aedes albopictus
parvovirus (AaPV) a denso-like virus, for Aedes aegypti mosquitoes. J Invertebr
Pathol 68: 299–309.
11. Ward TW, Jenkins MS, Afanasiev BN, Edwards M, Duda BA, et al. (2001)
Aedes aegypti transducing densovirus pathogenesis and expression in Aedes
aegypti and Anopheles gambiae larvae. Insect Mol Biol 10: 397–405.
12. Afanasiev BN, Kozlov YV, Carlson JO, Beaty BJ (1994) Densovirus of Aedes
aegypti as an expression vector in mosquito cells. Exp Parasitol 79: 322–339.
13. Konet DS, Anderson J, Piper J, Akkina R, Suchman E, et al. (2007) Short-
hairpin RNA expressed from polymerase III promoters mediates RNA
interference in mosquito cells. Insect Mol Biol 16: 199–206.
14. Barreau C, Jousset FX, Cornet M (1994) An efficient and easy method of
infection of mosquito larvae from virus-contaminated cell cultures. J Virol
Methods 49: 153–156.
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25:
402–408.
16. Gu JB, Dong YQ, Peng HJ, Chen XG (2010) A recombinant AeDNA
containing the insect-specific toxin, BmK IT1, displayed an increasing
pathogenicity on Aedes albopictus. Am J Trop Med Hyg 83: 614–623.
17. Bothwell AL, Paskind M, Reth M, Imanishi-Kari T, Rajewsky K, et al. (1981)
Heavy chain variable region contribution to the NPb family of antibodies:
somatic mutation evident in a gamma 2a variable region. Cell 24: 625–637.
18. Green MR (1991) Biochemical mechanisms of constitutive and regulated pre-
mRNA splicing. Annu Rev Cell Biol 7: 559–599.
19. Edwards HA, Harrison JB (1983) An osmoregulatory syncytium and associated
cells in a freshwater mosquito. Tissue Cell 15: 271–280.
20. Donini A, O’Donnell MJ (2005) Analysis of Na+, Cl-, K+,H + and NH4+
concentration gradients adjacent to the surface of anal papillae of the mosquito
Aedes aegypti: application of self-referencing ion-selective microelectrodes. J Exp
Biol 208: 603–610.
21. Brown AE, Crisanti A, Catteruccia F (2003) Comparative analysis of DNA
vectors at mediating RNAi in Anopheles mosquito cells and larvae. J Exp Biol
206: 1817–1823.
22. DeJong RJ, Miller LM, Molina-Cruz A, Gupta L, Kumar S, et al. (2007)
Reactive oxygen species detoxification by catalase is a major determinant of
Table 2. LT50 of virus-treated Ae. albopictus larvae.
Group LT50 (days) (95% CI)
Wild-type 10.00 (7.92–12.08) a
rAepAnSI-1, 8.00 (7.51–8.50) b
rAepAnSI-2 7.50 (7.01–7.99) b
rAepAeSI-1 7.50 (7.10–7.90) b
rAepAeSI-2 7.00 (6.64–7.36) c
The LT50 values were calculated from 200 larvae with each tested virus in
triplicate. Means within the same column with different letters are significantly
different (p,0.05).
doi:10.1371/journal.pone.0021329.t002
Recombinant Densovirus-Mediated RNA Interference
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e21329fecundity in the mosquito Anopheles gambiae. Proc Natl Acad Sci U S A 104:
2121–2126.
23. Pinto SB, Kafatos FC, Michel K (2007) The parasite invasion marker SRPN6
reduces sporozoite numbers in salivary glands of Anopheles gambiae. Cell
Microbiol 10: 891–898.
24. Isoe J, Rasco ´n AA Jr., Kunz S, Miesfeld RL (2009) Molecular genetic analysis of
midgut serine proteases in Aedes aegypti mosquitoes. Insect Biochem Mol Biol
39: 903–12.
25. Boisson B, Jacques JC, Choumet V, Martin E, Xu J, et al. (2006) Gene silencing
in mosquito salivary glands by RNAi. FEBS Lett 580: 1988–1992.
26. Akhtar S, Benter IF (2007) Nonviral delivery of synthetic siRNAs in vivo. J Clin
Invest 117: 3623–3632.
27. Sliva K, Schnierle BS (2010) Selective gene silencing by viral delivery of short
hairpin RNA. Virol J 7: 248.
28. Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, et al. (2009) A highly
efficient short hairpin RNA potently down-regulates CCR5 expression in
systemic lymphoid organs in the hu-BLT mouse model. Blood 115: 1534–1544.
29. Deng L, Li G, Xi L, Yin A, Gao Y, et al. (2009) Hepatitis B virus inhibition in
mice by lentiviral vector mediated short hairpin RNA. BMC Gastroenterol 9:
73.
30. Kim YJ, Ahn J, Jeung SY, Kim DS, Na HN, et al. (2008) Recombinant
lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus
sequences protect against viral myocarditis and improve survival rate in an
animal model. Virus Genes 36: 141–146.
31. Rossi JJ (2008) Expression strategies for short hairpin RNA interference triggers.
Hum Gene Ther 19: 313–317.
32. Amarzguioui M, Rossi JJ, Kim D (2005) Approaches for chemically synthesized
siRNA and vector-mediated RNAi. FEBS Lett 579: 5974–5981.
33. Stevens TH, Forgac M (1997) Structure, function and regulation of the vacuolar
(H+)-ATPase. Annu Rev Cell Dev Biol 13: 779–808.
34. Forgac M (1999) Structure and properties of the vacuolar (H+)-ATPases. J Biol
Chem 274: 12951–12954.
35. Wieczorek H, Brown D, Grinstein S, Ehrenfeld J, Harvey WR (1999) Animal
plasma membrane energization by proton-motive V-ATPases. Bioessays 21:
637–648.
36. Huang CG, Tsai KH, Wu WJ, Chen WJ (2006) Intestinal expression of H+ V-
ATPase in the mosquito Aedes albopictus is tightly associated with gregarine
infection. J Eukaryot Microbiol 53: 127–135.
37. Dimopoulos G, Richman A, della Torre A, Kafatos FC, Louis C (1996)
Identification and characterization of differentially expressed cDNAs of the
vector mosquito, Anopheles gambiae. Proc Natl Acad Sci U S A 93:
13066–13071.
38. Gill SS, Chu PB, Smethurst P, Pietrantonio PV, Ross LS (1998) Isolation of the
V-ATPase A and c subunit cDNAs from mosquito midgut and Malpighian
tubules. Arch Insect Biochem Physiol 37: 80–90.
39. Zhuang Z, Linser PJ, Harvey WR (1999) Antibody to H(+) V-ATPase subunit E
colocalizes with portasomes in alkaline larval midgut of a freshwater mosquito
(Aedes aegypti). J Exp Biol 202: 2449–2460.
40. Hunter CP, Winston WM, Molodowitch C, Feinberg EH, Shih J, et al. (2006)
Systemic RNAi in Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol
71: 95–100.
41. Tomoyasu Y, Miller SC, Tomita S, Schoppmeier M, Grossmann D, et al. (2008)
Exploring systemic RNA interference in insects: a genome-wide survey for RNAi
genes in Tribolium. Genome Biol 9: R10.
42. Price DR, Gatehouse JA (2008) RNAi-mediated crop protection against insects.
Trends Biotechnol 26: 393–400.
43. Bartsch D, Schuphan I (2002) Lessons we can learn from ecological biosafety
research. J Biotechnol 98: 71–77.
44. Mao YB, Cai WJ, Wang JW, Hong GJ, Tao XY, et al. (2007) Silencing a cotton
bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval
tolerance of gossypol. Nat Biotechnol 25: 1307–1313.
Recombinant Densovirus-Mediated RNA Interference
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21329